FR2426693B1 - - Google Patents

Info

Publication number
FR2426693B1
FR2426693B1 FR7913527A FR7913527A FR2426693B1 FR 2426693 B1 FR2426693 B1 FR 2426693B1 FR 7913527 A FR7913527 A FR 7913527A FR 7913527 A FR7913527 A FR 7913527A FR 2426693 B1 FR2426693 B1 FR 2426693B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7913527A
Other languages
French (fr)
Other versions
FR2426693A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FR2426693A1 publication Critical patent/FR2426693A1/fr
Application granted granted Critical
Publication of FR2426693B1 publication Critical patent/FR2426693B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7913527A 1978-05-26 1979-05-28 Antibiotique du type cephalosporine et son procede de preparation Granted FR2426693A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB22909/78A GB1604722A (en) 1978-05-26 1978-05-26 7-(2-(2-amino-4-thiozolyl)-2-oxymino-acetamido)-cephem derivatives

Publications (2)

Publication Number Publication Date
FR2426693A1 FR2426693A1 (fr) 1979-12-21
FR2426693B1 true FR2426693B1 (xx) 1983-02-04

Family

ID=10187026

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913527A Granted FR2426693A1 (fr) 1978-05-26 1979-05-28 Antibiotique du type cephalosporine et son procede de preparation

Country Status (9)

Country Link
JP (2) JPS54154788A (xx)
BE (2) BE876542A (xx)
CH (1) CH646704A5 (xx)
DE (1) DE2921288A1 (xx)
FR (1) FR2426693A1 (xx)
GB (1) GB1604722A (xx)
IT (1) IT1116196B (xx)
NL (1) NL7904127A (xx)
ZA (1) ZA792584B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE878514A (fr) * 1978-09-04 1980-02-29 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3-cephem-4-carboxylique a disubstitution en positions 3 et 7, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne
EP0346465B1 (en) * 1986-04-14 1993-08-11 Banyu Pharmaceutical Co., Ltd. 1-carboxy-1-vyniloxyiminoaminothiazole cephalosporing derivatives and process for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576625A (en) * 1976-04-12 1980-10-08 Fujisawa Pharmaceutical Co Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof

Also Published As

Publication number Publication date
NL7904127A (nl) 1979-11-28
BE876541A (fr) 1979-11-26
JPS54154788A (en) 1979-12-06
FR2426693A1 (fr) 1979-12-21
DE2921288A1 (de) 1979-12-06
CH646704A5 (en) 1984-12-14
IT7949177A0 (it) 1979-05-25
IT1116196B (it) 1986-02-10
JPS54154789A (en) 1979-12-06
ZA792584B (en) 1980-07-30
BE876542A (fr) 1979-11-26
GB1604722A (en) 1981-12-16

Similar Documents

Publication Publication Date Title
DE2925364C2 (xx)
DE2916540C2 (xx)
FR2415330B1 (xx)
FR2415078B1 (xx)
DE2844822C2 (xx)
DE2819441C2 (xx)
DE2953790A1 (xx)
FR2413979B3 (xx)
FR2414974B2 (xx)
FR2415248B1 (xx)
FR2426693B1 (xx)
AU3898778A (xx)
FR2414136B1 (xx)
FR2415694B1 (xx)
FR2414634B3 (xx)
FR2415135B1 (xx)
AU3803078A (xx)
DE2835796C3 (xx)
FR2415313B1 (xx)
FR2414292B1 (xx)
AU73950S (xx)
AU3892778A (xx)
CS193147B1 (xx)
BG25816A1 (xx)
BG25842A1 (xx)

Legal Events

Date Code Title Description
ST Notification of lapse